Jobs in Mid-America: Just a Sampling Graphic: Cathleen Heard Editor's Note: Continuing our five-part series on geographic issues that affect job hunting for life scientists, we now turn to Mid-America. Our boundaries may not be a true geographer's boundaries, but for our purposes, this area includes Ohio, Illinois, Indiana, and Michigan; goes south to Arkansas and Oklahoma; moves as far west as Colorado, Nebraska, the Dakotas, and Montana; and covers the states in between. In the next issue we'
Jobs in Mid-America: Just a Sampling
| Graphic: Cathleen Heard |
 |
Mid-America is the proverbial breadbasket of opportunity in agricultural biosciences, with many notable biomedical institutions dotting the landscape. Examples include the Cleveland Clinic in Ohio, the Mayo Clinic in Minnesota, Washington University in Missouri, a heavy concentration of medical schools and research in the Chicago area, and the University of Michigan.
"In the next decade I think the rate of growth [of ...
Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.
View this Issue
Experts from the Women’s Brain Foundation and bit.bio will explore the importance of sex-specific in vitro models for neurological research and drug discovery.
Discover how scientists are designing the next groundbreaking vaccines against infectious diseases.
In this webinar, Linghua Wang and Jeremy Goecks will talk about technology that enables new approaches for a better understanding of tumors on a cellular, spatial, and environmental level.
Explore how researchers use organoids to understand tissue regeneration and develop novel therapies.
Collaborative project with world leader in AI computing demonstrates Artificial workflows and model integration for self-driving generative virtual screening in drug discovery. Company also announces key accreditations in recognition of excellence in data security, AI innovation, and commitment to continuous improvement.
Partnership complements Sapient’s mass spectrometry-based proteomics services, extends multi-omics solutions, and will enable development of NULISAseq™ assays under regulated guidance
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of Vericheck ddPCR™ Empty-Full Capsid Kits for adeno-associated virus (AAV) serotypes 2 and 8, enabling determination of capsid titer, genome titer, and percentage of full capsids in purified or unpurified (crude lysate) samples.
Tailored nucleic acid extraction and amplification methods help scientists overcome the challenges of detecting Mycoplasma contamination in advanced therapy medicinal products.
